Antitrust and the U.S. Elections: Is the Past Prologue?
Axinn partners Richard Dagen, Lisl Dunlop, and Leslie Overton co-authored the article, Biden Antitrust Policy Skepticism Toward Private Equity Buyers in Healthcare Industry Mergers” for the for the Concurrences publication, “Antitrust and the U.S. Elections: Is the Past Prologue?”
FTC Finalizes Long-Awaited HSR Overhaul
Dealmakers have been on alert for the HSR overhaul to become final. That day has come, and this Axinn client alert is a first installment on what you need to know.
Axinn Partners Named to Lawdragon 500 Leading Dealmakers in America 2025
Axinn is pleased to announce that Lawdragon has recognized eight partners in its 2025 “500 Leading Dealmakers in America” guide.
Antitrust and the U.S. Elections: Is the Past Prologue?
Axinn partners Richard Dagen, Lisl Dunlop, and Leslie Overton co-authored the article, Biden Antitrust Policy Skepticism Toward Private Equity Buyers in Healthcare Industry Mergers” for the for the Concurrences publication, “Antitrust and the U.S. Elections: Is the Past Prologue?”
FTC Finalizes Long-Awaited HSR Overhaul
Dealmakers have been on alert for the HSR overhaul to become final. That day has come, and this Axinn client alert is a first installment on what you need to know.
Axinn Partners Named to Lawdragon 500 Leading Dealmakers in America 2025
Axinn is pleased to announce that Lawdragon has recognized eight partners in its 2025 “500 Leading Dealmakers in America” guide.
Antitrust and the U.S. Elections: Is the Past Prologue?
Axinn partners Richard Dagen, Lisl Dunlop, and Leslie Overton co-authored the article, Biden Antitrust Policy Skepticism Toward Private Equity Buyers in Healthcare Industry Mergers” for the for the Concurrences publication, “Antitrust and the U.S. Elections: Is the Past Prologue?”
Antitrust
Axinn’s full-service antitrust practice stands among the largest and most experienced. Our team works coast to coast and across borders to deliver integrated counsel on mergers and acquisitions (M&A), litigation, and government investigations.
Global Leader in Antitrust
Celebrated as a top-ranked antitrust practice by Chambers and Partners and Global Competition Review, Axinn is renowned for representing some of the world’s largest companies in matters of the highest strategic importance. Our track record of success includes leading high-profile civil and criminal litigations and investigations. Orchestrating approximately half a trillion dollars in M&A transactions, we have gained clearances for intensely contested deals, including the largest cash merger in U.S. history, the largest-ever tech deal, and other landmark transactions.
Unmatched Experience
We don't just understand the government authorities you'll face – we have inside agency experience. Our team of more than 70 dedicated antitrust lawyers includes former high-ranking officials from the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) as well as European Union antitrust regulators. Our dual perspective and experience enable us to tackle the most challenging multinational antitrust issues.
Deep Commitment to Client Success
Invested in our clients' success, we provide in-depth analysis and dedicated advocacy. Our inquisitive and incisive approach enables us to navigate the most complex legal issues with precision. We value collaboration and inclusivity, evidenced by our success in leading multijurisdictional teams to resolve sprawling litigations and advance cross-border deals.
Our reputation as tenacious advocates for strategic transactions is built on our track record of obtaining global clearances for multibillion-dollar deals combining industry rivals.
Axinn lawyers regularly serve as lead counsel, overseeing co-counsel around the world. Our diverse perspectives and experience make us adept at developing cohesive strategies to address regulators’ concerns head-on and gain approvals in the most challenging jurisdictions.
Experience:
- Broadcom’s $69 billion acquisition of VMware.
- Dell’s $67 billion acquisition of EMC.
- Thermo Fisher Scientific’s $13.2 billion acquisition of Life Technologies and $12.5 billion tender offer to acquire QIAGEN .
Axinn’s substantial experience as lead counsel in Section 7 challenges to mergers includes:
- Obtained a judgment rejecting the DOJ’s bid to block SunGard’s $825 million acquisition of Comdisco’s business recovery assets.
- Successfully litigated against the DOJ’s attempt to block George’s Inc.'s sale of assets to Tyson Foods after the sale had been completed.
- Successfully litigated against the City of New York in its efforts to stop Group Health Inc.'s acquisition of HIP Insurance Company.
Employing a sophisticated yet practical approach, Axinn has defended major industry players in some of the most high-profile and complex antitrust litigations and deal reviews in recent history. From private treble-damage class actions and sprawling multidistrict litigations (MDL) to price-fixing, bid-rigging, market allocation, and other antitrust claims, we resolve cases strategically and efficiently. Our experience extends to monopolization disputes, merger trials, criminal defense, and internal investigations.
Our inquisitive nature drives us to explore all facets of antitrust claims, ensuring comprehensive and diligent representation across industries. We consistently apply our creativity and bottom-line perspective to achieve exceptional outcomes in matters involving third-party subpoena defenses, leniency applications, antitrust compliance, and government investigations.
Experience:
- Representing Tyson Foods in multiple class action lawsuits alleging collusion among competitors.
- Representing Alvogen in the sprawling Generic Drugs MDL and in its antitrust counterclaims against Indivior relating to Alvogen’s launch of a generic equivalent to SUBOXONE®sublingual film.
- Representing Momenta Pharmaceuticals in a monopolization and class action lawsuit.
In today’s aggressive enforcement environment, the choice of cartel counsel is crucial. Lawyers must be incisive advisors, inquisitive strategists, and invested advocates. Axinn embodies these qualities.
We pride ourselves on handling the two largest price-fixing investigations of the past decade. We’ve represented clients in cartel investigations by major global authorities, including:
- DOJ
- Australian Competition and Consumer Commission
- Brazil’s Administrative Council for Economic Defense
- Canadian Competition Bureau
- European Commission
Our ranks include former federal prosecutors and leaders from the DOJ Antitrust Division who have overseen criminal investigations, trials, and policy initiatives. Leveraging our government experience, we take an integrated approach to managing all aspects of representation: compliance programs; internal investigations; government probes; criminal proceedings; and civil litigation.
We understand that each client’s goals and challenges are unique and devise tailored, creative strategies to resolve investigations.
We excel in leading complex matters at the intersection of antitrust and intellectual property (IP) laws. Combining our advanced technical training and focused IP experience, we regularly advise on standard-setting and fair, reasonable, and nondiscriminatory issues.
Clients call on us to conduct thorough internal investigations and to develop and implement robust antitrust compliance programs. Our client-centric approach empowers clients to navigate the most challenging antitrust landscapes with confidence.
Experience:
- Representing Google before FTC with respect to Standard Essential Patents
- Representing Red Hat before DOJ with respect to patent acquisitions
- Representing Motorola Mobility before FTC regarding patent issues
Insights
Event
|January 30, 2025
GCR Live: Law Leaders Global 2025
On January 30, Axinn partner Bradley Justus will speak on the "Antitrust: Theories of Harm in Unilateral Conduct Cases Concerning Big Tech in the U.S. and Europe" panel at Global Competition Review's Law Leaders Global Conference, being held January 29-31 in Miami. ...Read more
Event
|November 18, 2024
ALM General Counsel Conference East 2024
On November 18, Axinn partner Bradley Justus will speak on the "Antitrust in the Modern Era: Ensuring Corporate Compliance" panel at ALM's General Counsel Conference East, being held November 18-19 in New York. ...Read more
Event
|November 14, 2024
On November 14, Axinn and Slaughter & May will co-host a webinar exploring the evolving landscape of antitrust merger policy and foreign direct investment (FDI) in the wake of pivotal elections in the U.S., Europe, and around the world. ...Read more
Publications
|October 29, 2024
|less than 1 min read
Merger Program Overhaul Adds Compliance Burdens for Companies
Axinn antitrust practice chair Mike Keeley was quoted in the Bloomberg Law article “Merger Program Overhaul Adds Compliance Burdens for Companies." ...Read more
Publications
|October 29, 2024
|less than 1 min read
Tapestry Ruling Boosts New Merger Guidelines, Experts Say
Axinn partner Nick Gaglio was quoted in the Global Competition Review article, "Tapestry Ruling Boosts New Merger Guidelines, Experts Say."...Read more
Event
|October 26, 2024
AIJA IP/TMT Seminar // 11th Antitrust Annual Conference
On October 26, Axinn partner Dan Oakes will speak on the "Antitrust and Economics – Ups and (More?) Downs, Will the Love Story Come to an End?" at the International Association of Young Lawyers' IP/TMT Seminar // 11th Antitrust Annual Conference, being held October 24-26 in Málaga, Spain. ...Read more
Event
|October 26, 2024
National Women's Law Center Gala 2024
Axinn is pleased to sponsor the National Women's Law Center Gala on October 26 in Washington, DC. ...Read more
Event
|October 23, 2024
EDTX Bench Bar Conference 2024
Axinn is pleased to announce its sponsorship of the Eastern District of Texas Bar Association's Bench Bar Conference being held October 23-25 in Plano, Texas....Read more
Publications
|October 18, 2024
|less than 1 min read
Antitrust and the 2024 U.S. Elections: Is the Past Prologue?
Axinn partners Richard Dagen, Lisl Dunlop, and Leslie Overton co-authored the article, "Biden Antitrust Policy Skepticism Toward Private Equity Buyers in Healthcare Industry Mergers" for the Concurrences publication, "Antitrust and the 2024 U.S. Elections: Is the Past Prologue?"...Read more
News
|October 18, 2024
|1 min read
Axinn Partners Named to Lawdragon 500 Leading Dealmakers in America 2025
Axinn is pleased to announce that Lawdragon has recognized eight partners in its 2025 “500 Leading Dealmakers in America” guide....Read more
Practice Chair
Featured Insights
Featured Insights
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
NYC Bar Trade Secrets Symposium 2024: Navigating the Law of Trade Secrets and Restrictive Covenants
Speaking Engagement
Intellectual Property
Stakeholders 24th Annual CYOC Career Development Conference
Sponsorship
IAM Connect Patent Policy and Litigation Conference 2024
Speaking Engagement
Intellectual Property
CompLaw 33rd Annual Advanced EU Brussels Conference
Speaking Engagement
ALM General Counsel Conference East 2024
Speaking Engagement
Antitrust
Navigating Global Politics: The Future of Antitrust Merger Policy and Foreign Direct Investment (FDI)
Webinar
Antitrust
Global Legal Group Global Class Actions Symposium 2024
Speaking Engagement
Litigation & Trials
NAPABA Convention 2024
Sponsorship
Kisaco Research Pharma and Biotech Patent Litigation 2024
Speaking Engagement
Intellectual Property